The value of proteomics for the diagnosis of a platelet-related bleeding disorder

Platelets

Volumn 19, Issue 5, 2008, Pages 342-351

  Maurer Spurej, E ^a,b   Kahr, W H ^c   Carter, C J ^b   Pittendreigh, C ^a   Cameron, M ^d   Cyr, T D ^d  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

Delta storage pool disease; Platelets; Proteomics; Quebec Platelet Disorder (QPD)

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; BLOOD CLOTTING FACTOR 13; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; MULTIMERIN; PROTEIN DERIVATIVE; SEROTONIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; BLEEDING DISORDER; CONTROLLED STUDY; FIBRINOGEN BLOOD LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; QUEBEC PLATELET DISORDER; SEROTONIN RELEASE; TANDEM MASS SPECTROMETRY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; WESTERN BLOTTING;

ADENOSINE DIPHOSPHATE; BLEEDING TIME; BLOOD PLATELETS; BLOOD PROTEINS; COLLAGEN; CYTOPLASMIC GRANULES; ENZYME INDUCTION; EPINEPHRINE; FEMALE; GENES, DOMINANT; HEMORRHAGIC DISORDERS; HUMANS; MALE; PEDIGREE; PLATELET AGGREGATION; PROTEOMICS; QUEBEC; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 51849147909     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802010547     Document Type: Article

References (26)

1. Nurden AT. Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 2005;3:1773-1782.
2. Weiss HJ, Lages B. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity - a comparison with Scott syndrome. Blood 1997;89:1599-1611.
3. McNicol A, Israels SJ, Robertson C, Gerrard JM. The empty sack syndrome: A platelet storage pool deficiency associated with empty dense granules. Br J Haematol 1994;86:574-582.
4. Hayward CP, Rivard GE, Kane WH, Drouin J, Zheng S, Moore JC, Kelton JG. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996;87:4967-4978.
5. Kahr WH, Zheng S, Sheth PM, Pai M, Cowie A, Bouchard M, Podor TJ, Rivard GE, Hayward CP. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001;98:257-265.
6. Weiss HJ, Witte LD, Kaplan KL, Lages BA, Chernoff A, Nossel HL, Goodman DS, Baumgartner HR. Heterogeneity in storage pool deficiency: Studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979;54:1296-1319.
7. Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007;5:1945-1955.
8. Garcia A, Watson SP, Dwek RA, Zitzmann N. Applying proteomics technology to platelet research. Mass Spectrom Rev 2005;24:918-930.
9. Maguire PB, Foy M, Fitzgerald DJ. Using proteomics to identify potential therapeutic targets in platelets. Biochem Soc Trans 2005;33:409-412.
10. Garcia A, Prabhakar S, Brock CJ, Pearce AC, Dwek RA, Watson SP, Hebestreit HF, Zitzmann N. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004;4:656-668.
11. Maguire PB. Platelet proteomics: Identification of potential therapeutic targets. Pathophysiol Haemost Thromb 2003;33:481-486.
12. Gevaert K, Eggermont L, Demol H, Vandekerckhove J. A fast and convenient MALDI-MS based proteomic approach: Identification of components scaffolded by the actin cytoskeleton of activated human thrombocytes. J Biotechnol 2000;78:259-269.
13. Marcus K, Immler D, Sternberger J, Meyer HE. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 2000;21:2622-2636.
14. Garcia A, Senis YA, Antrobus R, Hughes CE, Dwek RA, Watson SP, Zitzmann N. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: Involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006;6:5332-5343.
15. Wittke S, Mischak H, Walden M, Kolch W, Radler T, Wiedemann K. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches. Electrophoresis 2005;26:1476-1487.
16. McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, Heddle NM, Rivard GE, Hayward CP. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004;104:159-165.
17. Maurer-Spurej E, Dyker K, Gahl WA, Devine DV. A novel immunocytochemical assay for the detection of serotonin in platelets. Br J Haematol 2002;116:604-611.
18. Watson SP, Bahou WF, Fitzgerald D, Ouwehand W, Rao AK, Leavitt AD. Mapping the platelet proteome: A report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 2005;3:2098-2101.
19. Holmsen H, Weiss HJ. Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia- "storage pool disease". Blood 1972;39:197-209.
20. Weiss HJ, Chervenick PA, Zalusky R, Factor A. A familial defect in platelet function associated with impaired release of adenosine diphosphate. N Engl J Med 1969;281R:1264-1270.
21. White JG, Rao GH. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol 1998;152:597-609.
22. Lo B, Li L, Gissen P, Christensen H, McKiernan PJ, Ye C, Abdelhaleem M, Hayes JA, Williams MD, Chitayat D, Kahr WH. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 2005;106:4159-4166.
23. Janeway CM, Rivard GE, Tracy PB, Mann KG. Factor V Quebec revisited. Blood 1996;87:3571-3578.
24. Sheth PM, Kahr WH, Haq MA, Veljkovic DK, Rivard GE, Hayward CP. Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder. Thromb Haemost 2003;90:293-298.
25. Kufrin D, Eslin DE, Bdeir K, Murciano JC, Kuo A, Kowalska MA, Degen JL, Sachais BS, Cines DB, Poncz M. Antithrombotic thrombocytes: Ectopic expression of urokinase-type plasminogen activator in platelets. Blood 2003;102:926-933.
26. Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function. Blood Rev 2008;3:155-172.